CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$0.72−0.02 (-2.35%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Creative Medical Technology has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Announcements Creative Medical Technology filed with the SEC

Parsed from the XBRL in Creative Medical Technology's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Jun 12, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CELZ.

Advertisement
300 × 250